Retraction notice to “Long noncoding RNA maternally expressed gene 3 knockdown alleviates lipopolysaccharide induced inflammatory injury by up-regulation of miR-203 in ATDC5 cells” [Biomed. Pharmacother. 100 (2018) 240–249]

Retraction notice to “Long noncoding RNA maternally expressed gene 3 knockdown alleviates lipopolysaccharide induced inflammatory injury by up-regulation of miR-203 in ATDC5 cells” [Biomed. Pharmacother. 100 (2018) 240–249]

Bibliographic Details
Main Authors:	Zhaolin Wang, Xiaohua Chi, Liping Liu, Yaqun Wang, Xiaoyan Mei, Yan Yang, Tanghong Jia
Format:	Article
Language:	English
Published:	Elsevier 2021-10-01
Series:	Biomedicine & Pharmacotherapy
Online Access:	http://www.sciencedirect.com/science/article/pii/S0753332221008830

Similar Items

Retraction Notice to “MicroRNA-1247 inhibits lipopolysaccharides-induced acute pneumonia in A549 cells via targeting CC chemokine ligand 16” [Biomed. Pharmacother. 104 (2018) 60–68]
by: Jinjing Guo, et al.
Published: (2021-10-01)

Retraction notice to “Autophagy is a pro-survival mechanism in ovarian cancer against the apoptotic effects of euxanthone” [Biomed. Pharmacother. 103 (2018) 708–718]
by: Li Zhu, et al.
Published: (2020-08-01)

Retraction notice to “NY-SAR-35 is involved in apoptosis, cell migration, invasion and epithelial to mesenchymal transition in glioma” [Biomed. Pharmacother. 97 (2018) 1632–1638]
by: Guangyong Wu, et al.
Published: (2020-05-01)

Astragaloside IV protects ATDC5 cells from lipopolysaccharide-caused damage through regulating miR-203/MyD88
by: Dexin Li, et al.
Published: (2020-01-01)

Retraction notice to “MicroRNA-30b promotes lipopolysaccharide-induced inflammatory injury and alleviates autophagy through JNK and NF-κB pathways in HK-2 cells” [Biomed. Pharmacother. 101 (2018) 842–851]
by: Lili Zhang, et al.
Published: (2020-08-01)

Retraction notice to “miR-149 regulates the proliferation and apoptosis of cervical canc er cells by targeting GIT1” [Biomed. Pharmacother. 105 (2018) 1106–1116]
by: Bing Qian, et al.
Published: (2020-05-01)

Retraction notice to “Baicalein inhibits proliferation and migration of bladder cancer cell line T24 by down-regulation of microRNA-106” [Biomed. Pharmacother. 107 (2018) 1583–1590]
by: Liangzhen Jiang, et al.
Published: (2020-10-01)

Retraction notice to “Amentoflavone suppresses hepatocellular carcinoma by repressing hexokinase 2 expression through inhibiting JAK2/STAT3 signaling” [Biomed Pharmacother. 107 (2018) 243–253]
by: Bo Liu, et al.
Published: (2020-10-01)

Corrigendum to “Exosomes: An emerging factor in atherosclerosis” [Biomed. Pharmacother. 115 (2019) 108951]
by: Yanan Wang, et al.
Published: (2019-10-01)

Retraction notice to “physcion 8-O-β-glucopyranoside inhibits clear-cell renal cell carcinoma bydownregulating hexokinase II and inhibiting glycolysis” [Biomed. Pharmacother. 104 (2018) 28–35]
by: Qiang Wang, et al.
Published: (2021-02-01)

Retraction notice to “LEF-1 gene silencing inhibits pulmonary vascular remodeling and occurrence of pulmonary arterial hypertension through the β-catenin signaling pathway” [Biomed. Pharmacother. 108 (2018) 817–827]
by: Xian-Feng Zhang, et al.
Published: (2020-08-01)

Retraction notice to “Cytokine augments the sorafenib-induced apoptosis in Huh7 liver cancer cell by inducing mitochondrial fragmentation and activating MAPK-JNK signalling pathway” [Biomed. Pharmacother. 110 (2019) 213–223]
by: Lijuan Zhang, et al.
Published: (2020-09-01)

Retraction notice to “Down-regulation of lncRNA ADAMTS9-AS2 contributes to gastric cancer development via activation of PI3K/Akt pathway” [Biomed. Pharmacother. 107 (2018) 185–193]
by: Bole Cao, et al.
Published: (2021-10-01)

Corrigendum to “Luteolin, a flavonoid, as an anticancer agent: A review” [Biomed. Pharmacother. 112 (2019) 108612]
by: Muhammad Imran, et al.
Published: (2019-08-01)

Corrigendum to “Dysbiosis of gut microbiota is associated with gastric carcinogenesis in rats” [Biomed Pharmacother. 126 (2020) 110036]
by: Chunyue Yu, et al.
Published: (2020-08-01)

Corrigendum to “Downregulation of long noncoding RNA HCP5 contributes to cisplatin resistance in human triple-negative breast cancer via regulation of PTEN expression” [Biomed. Pharmacother. 115 (2019) 108869]
by: Jingjing Wu, et al.
Published: (2020-02-01)

Corrigendum to “Nucleosome binding peptide presents laudable biophysical and in vivo effects” [Biomed. Pharmacother. 121 (2020) 109678]
by: Kaian Teles, et al.
Published: (2020-03-01)

Corrigendum to “Ginsenoside Rd contributes the attenuation of cardiac hypertrophy in vivo and in vitro” [Biomed. Pharmacother. 109 (2019) 1016–1023]
by: Ningning Zhang, et al.
Published: (2020-10-01)

Corrigendum to “Umbelliferone (7-hydroxycoumarin): A non-toxic antidiarrheal and antiulcerogenic coumarin” [Biomed. Pharmacother. 129 (2020) 110432]
by: Luisa Ferreira da Cruz, et al.
Published: (2020-10-01)

Corrigendum to: “Novel and emerging mutations of SARS-CoV-2: Biomedical implications” [Biomed. Pharmacother. 139 (2021) 111599]
by: Elmira Mohammadi, et al.
Published: (2021-08-01)

Corrigendum to “Nrf2 transcriptional activity in the mouse affects the physiological response to tribromoethanol” [Biomed. Pharmacother. 128 (2020) 110317]
by: Aleksandra Kopacz, et al.
Published: (2021-01-01)

Corrigendum to ‘Physiological and pathophysiological roles of Acidic mammalian chitinase (CHIA) in multiple organs’ [Biomed. Pharmacother. 138 (2021) 111465]
by: Chunli Hu, et al.
Published: (2021-07-01)

Corrigendum to ‘Innovated formulation of TCM pangolin scales to develop a nova therapy of rheumatoid arthritis’ [Biomed. Pharmacother. 126 (2020) 109872]
by: Huiqing Lv, et al.
Published: (2021-08-01)

Corrigendum to “Chrysin-nanoencapsulated PLGA-PEG for macrophage repolarization: Possible application in tissue regeneration” [Biomed. Pharmacother. 105 (2018) 773–780]
by: Akram Firouzi-Amandi, et al.
Published: (2019-10-01)

Corrigendum to “Pro-apoptotic effects of Amblyomin-X in murine renal cell carcinoma “in vitro” [Biomed. Pharmacother. 66 (2012) 64–69]
by: Erica Mie Akagi, et al.
Published: (2019-10-01)

Corrigendum to “Study on the efficacy and mechanism of triptolide on treating TNF transgenic mice with rheumatoid arthritis” [Biomed. Pharmacother. 106 (2018) 813–820]
by: Shengli Wang, et al.
Published: (2019-03-01)

Corrigendum to “Linc00152 promotes tumorigenesis by regulating DNMTs in triple-negative breast cancer” [Biomed Pharmacother. 97 (2018) 1275–1281]
by: Jiali Wu, et al.
Published: (2020-07-01)

Ascorbate-enhanced chondrogenesis of ATDC5 cells
by: F M Altaf, et al.
Published: (2006-11-01)

Corrigendum to “Ac2-26 ameliorates lung ischemia-reperfusion injury via the eNOS pathway” [Biomed. Pharmacother. 117 (2019) 109194]
by: Jing Gong, et al.
Published: (2020-10-01)

Corrigendum to “New insights into long non-coding RNAs in non-small cell lung cancer” [Biomed. Pharmacother. 131 (November) (2020) 110775]
by: Ruifang Ye, et al.
Published: (2020-12-01)

Corrigendum to “Intrinsic β-catenin signaling suppresses CD8 + T-cell infiltration in colorectal cancer” [Biomed. Pharmacother. 115 (May) (2019) 108921]
by: Junli Xue, et al.
Published: (2020-12-01)

Corrigendum to “miR-10b promotes invasion by targeting KLF4 in osteosarcoma cells” [Biomed. Pharmacother. 84 (2016) 947–953]
by: Jing Wang, et al.
Published: (2020-08-01)

Corrigendum to “Evaluation of antiviral effect and toxicity of total flavonoids extracted from Robinia pseudoacacia cv. idaho” [Biomed. Pharmacother. 118 (2019) 109335]
by: Hao Guo, et al.
Published: (2020-03-01)

Mangiferin Relieves Lipopolysaccharide-Induced Injury by Up-Regulating miR-181a via Targeting PTEN in ATDC5 Cells
by: Yunfei Ma, et al.
Published: (2020-03-01)

Corrigendum to “Berberine associated photodynamic therapy promotes autophagy and apoptosis via ROS generation in renal carcinoma cells” [Biomed. Pharmacother. 123 (2020) 109794]
by: Tairine Zara Lopes, et al.
Published: (2021-04-01)

Corrigendum to “Baohuoside-1 targeting mTOR inducing apoptsis to inhibit hepatocellular carcinoma proliferation, invasion and migration” [Biomed. Pharmacother. 128 (2020) 110366]
by: Yangyang Guo, et al.
Published: (2020-09-01)

Corrigendum to “Baohuoside-1 targeting mTOR inducing apoptsis to inhibit hepatocellular carcinoma proliferation, invasion and migration” [Biomed. Pharmacother. 2020 (128) 110366]
by: Yangyang Guo, et al.
Published: (2020-10-01)

Corrigendum to “MiR-25-3p promotes malignant phenotypes of retinoblastoma by regulating PTEN/Akt pathway” [Biomed. Pharmacother. 118 (2019) 109111]
by: Wencui Wan, et al.
Published: (2020-11-01)

Corrigendum to ‘Proteomic changes in the hippocampus and motor cortex in a rat model of cerebral palsy: Effects of topical treatment’ [Biomed. Pharmacother. 133 (2021) 110844]
by: Tao Wang, et al.
Published: (2021-08-01)

Corrigendum to “Prolyl oligopeptidase inhibition by KYP-2407 increases alpha-synuclein fibril degradation in neuron-like cells” [Biomed. Pharmacother. 131 (2020) 110788]
by: Jinar Rostami, et al.
Published: (2021-01-01)